BillionToOne, Inc Class A Common Stock

Yahoo Finance • 13 days ago

What Makes BillionToOne (BLLN) a Revolutionizer in Genetic Testing?

Baron Capital, an investment management company, released its Q1 2026 investor letter for the “Baron Health Care Fund”. A copy of the letter is available to download here. Baron Health Care Fund (the Fund) declined 6.97% (Institutional Sha... Full story

Yahoo Finance • 16 days ago

Discover 3 Stocks That Might Be Trading Below Estimated Value

In the last week, the United States market has stayed flat, although it is up 29% over the past year with earnings forecasted to grow by 16% annually. In such a climate, identifying stocks that might be trading below their estimated value... Full story

Yahoo Finance • 17 days ago

Jim Cramer Believes “BillionToOne’s a Winner”

BillionToOne, Inc. (NASDAQ:BLLN) was among the stocks Jim Cramer covered on Mad Money as he discussed the wave of IPOs being the market’s possible biggest threat. When a caller inquired about the stock, Cramer said: We looked into Billion... Full story

Yahoo Finance • last month

BillionToOne to Report First Quarter 2026 Financial Results on May 6, 2026

MENLO PARK, Calif., April 15, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced th... Full story

Yahoo Finance • 3 months ago

BillionToOne to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026

MENLO PARK, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced tha... Full story

Yahoo Finance • 3 months ago

Fund Slashes Chime Stake by Nearly $10 Million as Shares Sit 27% Below IPO Price

On February 13, 2026, Singapore-based Napean Trading & Investment reported selling 449,981 shares of Chime Financial(NASDAQ:CHYM), an estimated $9.56 million trade based on quarterly average pricing. What happened According to an SEC fil... Full story

Yahoo Finance • 3 months ago

BillionToOne Stock at $89: Why a New $19.1 Million Position Could Matter Now

On February 13, 2026, Singapore-based Napean Trading & Investment disclosed a new position in BillionToOne (NASDAQ:BLLN), acquiring 233,333 shares in a transaction valued at $19,095,973, according to an SEC filing. What happened Accordin... Full story

Yahoo Finance • 3 months ago

Navan Stock Plunges 60% From $25 IPO, but This $100 Million Stake Makes Up 20% of a Portfolio

Singapore-based Napean Trading & Investment disclosed a new stake in Navan(NASDAQ:NAVN) in its February 13, 2026, SEC filing, acquiring 5,874,257 shares in an estimated $100.33 million trade. What happened According to its SEC filing dat... Full story

Yahoo Finance • 3 months ago

3 Stocks Estimated To Be Up To 39.1% Below Intrinsic Value Offering A Possible Opportunity

As February 2026 begins, major U.S. stock indexes have shown strong upward momentum, with the Dow Jones Industrial Average gaining 515 points and the S&P 500 nearing a record high. In this environment of robust market performance and econo... Full story

Yahoo Finance • 3 months ago

Insiders Favor These 3 High Growth Companies

As the U.S. stock market kicked off February with a strong performance, highlighted by significant gains in major indices like the Dow Jones and S&P 500, investors are keenly observing growth companies that insiders are heavily investing i... Full story

Yahoo Finance • 5 months ago

BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference

BillionToOne, Inc. MENLO PARK, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, t... Full story

Yahoo Finance • 5 months ago

BillionToOne Appoints Anthony Pagano to Board of Directors as Audit Committee Chair

MENLO PARK, Calif., Dec. 9, 2025 /PRNewswire/ – BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced the appoint... Full story

Yahoo Finance • 5 months ago

BillionToOne Reports Third Quarter 2025 Results

MENLO PARK, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today reported its... Full story

Yahoo Finance • 5 months ago

AppLovin Stock Rides Swarm Of Setups Beyond Just Mining, Medical Names

As mining and medical stocks dominate this breakout screen, Alphabet and AppLovin stock look to keep the AI party going. Continue Reading... Full story

Yahoo Finance • 5 months ago

BillionToOne to Report Third Quarter 2025 Financial Results on December 9, 2025

MENLO PARK, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that the Company pl... Full story